During the past decade, CROSS Research S.A. - Phase I Unit conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CROSS Research S.A. - Phase I Unit" #1 sponsor was "Aziende Chimiche Riunite Angelini Francesco S.p.A" with 7 trials, followed by "Crucell Holland BV" with 2 trials sponsored, "Cross Research S.A." with 1 trials sponsored, "Dompé Farmaceutici S.p.A" with 1 trials sponsored and "Medicines for Malaria Venture" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CROSS Research S.A. - Phase I Unit" #1 collaborator was "Cross Research S.A." with 9 trials as a collaborator, "Shin Poong Pharmaceuticals" with 1 trials as a collaborator, "Zambon SpA" with 1 trials as a collaborator and "eResearch Technology, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "CROSS Research S.A. - Phase I Unit" are "Healthy" (8 trials), "Influenza" (2 trials), "Healthy Women" (1 trials), "Malaria" (1 trials) and "Pain Disorders" (1 trials). Many other conditions were trialed in "CROSS Research S.A. - Phase I Unit" in a lesser frequency.

Most popular intervention types in "CROSS Research S.A. - Phase I Unit" are "Drug" (11 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "100 mg safinamide" (1 trials), "20 mg rosuvastatin calcium period 1" (1 trials), "20 mg rosuvastatin calcium period 2" (1 trials), "Diclofenac sodium" (1 trials) and "Diclofenac sodium and safinamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "CROSS Research S.A. - Phase I Unit" are 11 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "CROSS Research S.A. - Phase I Unit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in CROSS Research S.A. - Phase I Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CROSS Research S.A. - Phase I Unit, 11 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".